Cited by 1,573Computational Drug Discovery MethodsMachine Learning in Materials ScienceProtein Degradation and Inhibitors

The DOI matches its Crossref record; 49 of the 57 references it cites were found in a registry or an index.

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Zhavoronkov, Alex, Ivanenkov, Yan A., Aliper, Alex, Veselov, Mark S., Aladinskiy, Vladimir A., Aladinskaya, Anastasiya V., Terentiev, Victor A., Polykovskiy, Daniil A., Kuznetsov, Maksim D., Asadulaev, Arip, Volkov, Yury, Zholus, Artem, Shayakhmetov, Rim R., Zhebrak, Alexander, Minaeva, Lidiya I., Zagribelnyy, Bogdan A., Lee, Lennart H., Soll, Richard, Madge, David, Xing, Li, Guo, Tao, Aspuru-Guzik, Alán·2019·Nature Biotechnology

DOI 10.1038/s41587-019-0224-x

Open this paper in CoChat — free account

Abstract

We have developed a deep generative model, generative tensorial reinforcement learning (GENTRL), for de novo small-molecule design. GENTRL optimizes synthetic feasibility, novelty, and biological activity. We used GENTRL to discover potent inhibitors of discoidin domain receptor 1 (DDR1), a kinase target implicated in fibrosis and other diseases, in 21 days. Four compounds were active in biochemical assays, and two were validated in cell-based assays. One lead candidate was tested and demonstrated favorable pharmacokinetics in mice.

Integrity signals

Registry

Crossref · 10.1038/s41587-019-0224-x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
Learning Phrase Representations using RNN Encoder–Decoder for Statistical Machine Translation
Cho, K., van Merrienboer, B., Gulcehre, C., Bahdanau, D., Bougares, F., Schwenk, H., & Bengio, Y. (2014) · Proceedings of the 2014 Conference on Empirical Methods in Natural Language Processing (EMNLP) · doi:10.3115/v1/d14-1179 · Cited by 25,545
GAN（Generative Adversarial Nets）
淳司, 柴. (2017) · Journal of Japan Society for Fuzzy Theory and Intelligent Informatics · doi:10.3156/jsoft.29.5_177_2 · Cited by 20,507
UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations
Rappé, A. K., Casewit, C. J., Colwell, K. S., Goddard, W. A., & Skiff, W. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00051a040 · Cited by 10,603
Simple Statistical Gradient-Following Algorithms for Connectionist Reinforcement Learning
Williams, R. J. (1992) · Machine Learning · doi:10.1007/bf00992696 · Cited by 8,608
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
A Nonlinear Mapping for Data Structure Analysis
Sammon, J. W. (1969) · IEEE Transactions on Computers · doi:10.1109/t-c.1969.222678 · Cited by 3,364
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Self-citation
Tensor-Train Decomposition
Oseledets, I. V. (2011) · SIAM Journal on Scientific Computing · doi:10.1137/090752286 · Cited by 2,860
ZINC: A Free Tool to Discover Chemistry for Biology
Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S. D., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,611

Show all 57 references

Research works printed but not linked: 2

Goodfellow, I. et al. Generative adversarial nets. in Advances in Neural Information Processing Systems 2672–2680 (2014).
Williams, R. J. Mach. Learn. 8, 229–256 (1992).

Sorted by citations

Items 701–800 of 999

Yin-yang in drug discovery: rethinking de novo design and development of predictive models
Chávez‐Hernández, A. L., López‐López, E., & Medina‐Franco, J. L. (2023) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2023.1222655 · Cited by 9
Multi-layered perceptron and its applications in biotechnology
Zhu, H. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/20/20230753 · Cited by 12
Integration of Federated Learning and Blockchain in Health Care: Tutorial on Medical Data, Architectures, Privacy, Security, and Regulatory Compliance
Shahsavari, Y., Baseri, Y., Hafid, A. S., Dambri, O. A., & Makrakis, D. (2026) · Journal of Medical Internet Research · doi:10.2196/80178 · Cited by 24
Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence
Urbina, F., Jones, T., Harris, J. S., Snyder, S. H., Lane, T. R., & Ekins, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00405 · Cited by 11
Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
Zhang, Y., Yu, J.-G., & Wen, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116731 · Cited by 9
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency
Iwata, H. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2437283 · Cited by 9
Multimodal omics analysis of the EGFR signaling pathway in non-small cell lung cancer and emerging therapeutic strategies
Li, Y. L., YU, L., ZHOU, S., Zhou, H., & Wu, Q. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2025.059311 · Cited by 10
The AI-Driven Future of Drug Discovery: Innovations, Applications, and Challenges
Pache, M. M., Pangavhane, R. R., Jagtap, M. N., & Darekar, A. B. (2025) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2025.00009 · Cited by 10
The Role of Artificial Intelligence in Drug Discovery and Pharmaceutical Development: A Paradigm Shift in the History of Pharmaceutical Industries
Vidiyala, N., Sunkishala, P., Parupathi, P. R., & Nyavanandi, D. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03134-3 · Cited by 10
A 3D pocket-aware lead optimization model with knowledge guidance and its application for discovery of new glutaminyl cyclase inhibitors
Qiao, A., Chen, Y., Xie, J., Huang, W., Zhang, H., Deng, Q., Rao, J., Deng, J. W., Meng, F., Wang, Z., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf345 · Cited by 9
Artificial intelligence in materials science and chemistry: Past, present and future trajectories
Osaro, E., Karpinski, N., Alornyo, S., & Ighalo, J. O. (2025) · Materials Today Chemistry · doi:10.1016/j.mtchem.2025.103115 · Cited by 11
AI-enabled, QbD-aligned Predictive, and Sustainable Design of Natural Polymer-based Drug Delivery Systems
Suksaeree, J., Maneewattanapinyo, P., & Monton, C. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03326-5 · Cited by 14
Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical Innovation
Ali, M. S., Alqahtani, T., Shmrany, H. A., Gupta, G., Goh, K. W., Sahebkar, A., & Kesharwani, P. (2026) · Drug Development Research · doi:10.1002/ddr.70281 · Cited by 11
A Multitask Deep-Learning Method for Predicting Membrane Associations and Secondary Structures of Proteins
Li, B., Mendenhall, J., Capra, J. A., & Meiler, J. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00410 · Cited by 10
DeepGAN: Generating Molecule for Drug Discovery Based on Generative Adversarial Network
Xu, M., Cheng, J., Liu, Y., & Huang, W. (2021) · IEEE Symposium on Computers and Communications (ISCC) · doi:10.1109/iscc53001.2021.9631396 · Cited by 10
Advances in computer-aided drug design for type 2 diabetes
Huang, W., Zhang, L., & Li, Z. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2047644 · Cited by 9
Deep learning in drug discovery: applications and limitations
Tang, Y. (2023) · Frontiers in Computing and Intelligent Systems · doi:10.54097/fcis.v3i2.7575 · Cited by 10
Model-Agnostic Federated Learning
Mittone, G., Riviera, W., Colonnelli, I., Birke, R., & Aldinucci, M. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-39698-4_26 · Cited by 9
1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
Kazakova, E., Lane, T. R., Jones, T., Puhl, A. C., Riabova, O., Makarov, V., & Ekins, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c06106 · Cited by 10
Bayesian Optimization in the Latent Space of a Variational Autoencoder for the Generation of Selective FLT3 Inhibitors
Chandra, R., Horne, R. I., & Vendruscolo, M. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c01224 · Cited by 9
Targeting ion channels with ultra-large library screening for hit discovery
Melançon, K. M., Pliushcheuskaya, P., Meiler, J., & Künze, G. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1336004 · Cited by 9
A deep learning and digital archaeology approach for mosquito repellent discovery
Wei, J. N., Ruiz, C., Vlot, M., Sanchez-Lengeling, B., Lee, B. K., Berning, L., Vos, M. W., Henderson, R., Qian, W. W., Sanders, J. N., et al. (2025) · Chemical Senses · doi:10.1093/chemse/bjaf021 · Cited by 9
Deep Learning-Based Ligand Design Using Shared Latent Implicit Fingerprints from Collaborative Filtering
Srinivas, R., Verma, N., Kraka, E., & Larson, E. C. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01355 · Cited by 9
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS‐CoV‐2
Rabhi, Y., Mrabet, M., & Fnaiech, F. (2021) · BioMed Research International · doi:10.1155/2021/6696012 · Cited by 9
LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19
(2022) · doi:10.1016/j.isci.2022.105314 · Cited by 9
Application of Computing as a High-Practicability and -Efficiency Auxiliary Tool in Nanodrugs Discovery
Xu, K., Li, S., Zhou, Y., Gao, X., Mei, J., & Liu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041064 · Cited by 9
Machine-learning accelerated annealing with fitting-search style for multicomponent alloy structure predictions
Li, C.-N., Liang, H.-P., Duan, Y., & Lin, Z. (2023) · Physical Review Materials · doi:10.1103/physrevmaterials.7.033802 · Cited by 9
Chemistry42: An AI-based platform for de novo molecular designPreprint
Ivanenkov, Y. A., Zhebrak, A., Bezrukov, D. S., Zagribelnyy, B. A., Aladinskiy, V., Polykovskiy, D. A., Lane, E., Kamya, P. R. N., Aliper, A. M., & Zhavoronkov, A. A. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2101.09050 · Cited by 12
Self-citation
3D-Transformer: Molecular Representation with Transformer in 3D SpacePreprint
Wu, F., Zhang, Q., Radev, D., Cui, J., Zhang, W., Xing, H., Zhang, N., & Chen, H. (2021) · arXiv (Cornell University) · Cited by 9
An Artificial Intelligence Framework for Optimal Drug DesignPreprint
Ramey, G. D., Vargas, S., de Alwis, D. P., Alexandrova, A. N., Distefano, J., & Bloomingdale, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.29.514379 · Cited by 9
Generating Bioactive Natural Product-inspired Molecules with Machine Intelligence
Schneider, P., Altmann, K., & Schneider, G. (2022) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2022.396 · Cited by 9
Human F-ATP synthase as a drug target
Gerle, C., Jiko, C., Nakano, A., Yokoyama, K., Gopalasingam, C. C., Shigematsu, H., & Abe, K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107423 · Cited by 9
Improving Molecular Design with Direct Inverse Analysis of QSAR/QSPR Model
Shino, Y., & Kaneko, H. (2025) · Molecular Informatics · doi:10.1002/minf.202400227 · Cited by 9
ICVAE: Interpretable Conditional Variational Autoencoder for De Novo Molecular Design
Fan, X., Fang, S., Li, Z., Ji, H., Yue, M., Li, J., & Ren, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093980 · Cited by 10
Artificial intelligence in biology and medicine
Iskuzhina, L., Turaev, Z., Rozhin, A. O., Романов, А. А., Skomorokhova, E. A., Ishmukhametov, I., & Rozhina, E. V. (2025) · Die Naturwissenschaften · doi:10.1007/s00114-025-02029-4 · Cited by 7
Artificial intelligence in protein-based detection and inhibition of AMR pathways
Sadhukhan, S., Bhattacharya, R., Bhattcharya, D., Sahana, S., Pradhan, B., Pandit, S., Gill, H. S., Rajeev, M., Nag, M., & Lahiri, D. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00710-4 · Cited by 10
Artificial intelligence‐enabled digital biomedical engineering
Song, P., Tang, X., Lv, X., Reis, R. L., Chen, X., Bai, L., & Su, J. (2025) · BMEMat · doi:10.1002/bmm2.70049 · Cited by 9
Artificial intelligence-generated content (AIGC) in biomedical research, healthcare delivery, and clinical practices: technologies, applications, and regulatory considerations
Ye, J. (2026) · Artificial Intelligence Review · doi:10.1007/s10462-025-11487-1 · Cited by 9
AI in Drug Discovery: Clinical Failures, Regulatory Reality, and the Validation Crisis Behind the Hype
Khairil, L., Benny, K. H. S., Jerry, J., Khatib, F. M., Ramli, M. D. C., & Kumar, S. (2026) · Pharmaceuticals · doi:10.3390/ph19060916 · Cited by 11
Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies
Jiang, S., Tuzikov, A. V., & Andrianov, A. M. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.03.009 · Cited by 9
Genomics-based tools for drug discovery and development: From network maps to efficacy prediction
Fang, J., Qi, C., & Wu, G. (2023) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2023.11.001 · Cited by 9
Instruction multi-constraint molecular generation using a teacher-student large language model
Zhou, P., Wang, J., Li, C., Wang, Z., Liu, Y., Sun, S., Lin, J., Wei, L., Lai, H., Lai, H., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02200-3 · Cited by 10
Digital Medicine – The New Frontier for AI in Healthcare
Ho, D., & Teo, G. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000015 · Cited by 8
RGAN: Rényi Generative Adversarial Network
Sarraf, A., & Nie, Y. (2021) · SN Computer Science · doi:10.1007/s42979-020-00403-9 · Cited by 8
Multitask deep learning with dynamic task balancing for quantum mechanical properties prediction
Yang, Z., Zhong, W., Lv, Q., & Chen, C. Y. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp05172e · Cited by 8
Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation
Nakarin, F., Boonpalit, K., Kinchagawat, J., Wachiraphan, P., Rungrotmongkol, T., & Nutanong, S. Y. (2022) · Molecules · doi:10.3390/molecules27041226 · Cited by 8
Self-learning entropic population annealing for interpretable materials design
Li, J., Zhang, J., Tamura, R., & Tsuda, K. (2022) · Digital Discovery · doi:10.1039/d1dd00043h · Cited by 8
Reinforcement learning supercharges redox flow batteries
Cao, Y., Ser, C. T., Skreta, M., Jorner, K., Kusanda, N., & Aspuru‐Guzik, A. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00523-2 · Cited by 8
Self-citation
ReMODE: a deep learning-based web server for target-specific drug design
Wang, M., Wang, J., Weng, G., Kang, Y., Pan, P., Li, D., Deng, Y., Li, H., Hsieh, C., & Hou, T. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00665-w · Cited by 8
Towards Better Opioid Antagonists Using Deep Reinforcement LearningPreprint
Deng, J., Yang, Z., Li, Y., Samaras, D., & Wang, F. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.04768 · Cited by 10
Probabilistic Machine Learning for Healthcare
Chen, I. Y., Joshi, S. D., Ghassemi, M., & Ranganath, R. (2021) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-092820-033938 · Cited by 68
Machine Learning Uncovers Natural Product Modulators of the 5-Lipoxygenase Pathway and Facilitates the Elucidation of Their Biological Mechanisms
Mikutis, S., Lawrinowitz, S., Kretzer, C., Dunsmore, L., Sketeris, L., Rodrigues, T., Werz, O., & Bernardes, G. J. L. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00725 · Cited by 7
De novo drug design through gradient-based regularized search in information-theoretically controlled latent space
Jang, H., Seo, S., Park, S., Kim, B. J., Choi, G.-W., Choi, J., & Park, C. (2024) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-024-00571-3 · Cited by 7
Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
Miljković, F. N., & Bajorath, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00659 · Cited by 8
Deep Multitask Learning-Driven Discovery of New Compounds Targeting Leishmania infantum
Santos, E. S. D. A., Lemos, J. M., Carvalho, A. M. D. S., de Melo, F. D. S. M., Pereira, E. D. S., Moreira‐Filho, J. T., Braga, R. C., Muratov, E. N., Grellier, P., Charneau, S. O., et al. (2024) · ACS Omega · doi:10.1021/acsomega.4c07994 · Cited by 7
Machine learning-powered, high-affinity modification strategies for aptamers
Gubu, A., Yang, X., Luo, H., Yu, S., Zhang, H., Tian, Y., Yu, Y., Ding, S., Pan, Y., Chen, Z., et al. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0065 · Cited by 7
Retro-forward synthesis design and experimental validation of potent structural analogs of known drugs
Makkawi, A., Beker, W., Wołos, A., Manna, S., Roszak, R., Szymkuć, S., Moskal, M., Koshevarnikov, A., Molga, K., Żądło‐Dobrowolska, A., et al. (2025) · Chemical Science · doi:10.1039/d5sc00070j · Cited by 7
Emerging strategies and translational advancements of DDR1 in oncology
Luo, Y., Liu, T., Pei, J., Xu, S., Liu, J., & Yu, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02107-z · Cited by 7
A Systematic Review of AI-Driven Innovations in Drug Development, Precision Medicine, and Healthcare
Uriti, S. V. (2025) · Journal of Pharma Insights and Research. · doi:10.69613/nvj8x122 · Cited by 7
Reimagining ethnopharmacology with generative AI: Towards inclusive, ethical, and data-driven traditional medicine
Bhadra, S., Pundir, C., Mukherjee, M., Kar, A., Banerjee, S., Charoensup, R., Duangyod, T., & Mukherjee, P. K. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108002 · Cited by 10
Bridging traditional and contemporary approaches in computational medicinal chemistry: opportunities for innovation in drug discovery
de Oliveira, A. S. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00700c · Cited by 10
Next-generation drug discovery: The AI revolution in pharmaceutical research
Bilotta, M., Rocca, R., & Alcaro, S. (2025) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2025.100149 · Cited by 11
From Algorithm to Medicine: AI in the Discovery and Development of New Drugs
Lopes, A. B. S., Rodrigues, C. F., & Silva, F. A. M. (2026) · AI · doi:10.3390/ai7010026 · Cited by 10
Molecular Design with Artificial Intelligence: Progress and Perspectives for Small Molecules
Sumita, M., Ishida, S., Yoshizoe, K., Tamura, R., Terayama, K., & Tsuda, K. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00689 · Cited by 11
Artificial Intelligence in Healthcare Administration and Clinical Informatics: A Critical Review and Governance Roadmap
Aldosari, H. (2026) · Healthcare · doi:10.3390/healthcare14111497 · Cited by 8
Improving drug discovery with a hybrid deep generative model using reinforcement learning trained on a Bayesian docking approximation
Xiong, Y., Wang, Y., Wang, Y., Li, C., Yusong, P., Wu, J., Wang, Y., Gu, L., & Butch, C. J. (2023) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-023-00523-3 · Cited by 7
Closing the Execution Gap in Generative AI for Chemicals and Materials: Freeways or Safeguards
Subramanian, A., Gao, W., Barzilay, R., Grossman, J. C., Jaakkola, T., Jegelka, S., Li, M., Li, J., Matusik, W., Olivetti, E., et al. (2024) · An MIT Exploration of Generative AI · doi:10.21428/e4baedd9.92e511e3 · Cited by 7
A Specialized and Enhanced Deep Generation Model for Active Molecular Design Targeting Kinases Guided by Affinity Prediction Models and Reinforcement Learning
Liu, X., Li, Q., Xiao, Y., Wang, L., Qiu, J., Yao, X., & Liu, H. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00074 · Cited by 8
El impacto de la inteligencia artificial en la producción científica
Solís, A. K. G., Muñoz, G. F. R., González, D. A. Y., & Sánchez-Lascano, M. N. (2025) · Multidisciplinary Latin American Journal (MLAJ) · doi:10.62131/mlaj-v3-n1-031 · Cited by 14
Generating Novel Compounds Targeting SARS-CoV-2 Main Protease Based on Imbalanced Dataset
Hu, F., Wang, D., Hu, Y., Jiang, J., & Yin, P. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313317 · Cited by 7
Application of Docking for Lead Optimization
Patra, J., Singh, D., Jain, S., & Mahindroo, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822312-3.00012-6 · Cited by 8
Understanding collagen interactions and their targeted regulation by novel drugs
Gallorini, M., & Carradori, S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1933426 · Cited by 9
The commoditization of AI for molecule design
Urbina, F., & Ekins, S. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100031 · Cited by 7
Inteligencia artificial en el diseño de fármacos: hacia la inteligencia aumentada
Saldívar‐González, F. I., Gortari, E. F., & Medina‐Franco, J. L. (2023) · Educación Química · doi:10.22201/fq.18708404e.2023.2.83233 · Cited by 6
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles
Thomas, J. R., Shelton, C., Murphy, J., Brittain, S. M., Bray, M., Aspesi, P., Concannon, J. B., King, F. J., Ihry, R. J., Ho, D. J., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00737 · Cited by 7
Introduction: An Overview of AI in Oncology Drug Discovery and Development
Linton‐Reid, K. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92799 · Cited by 8
Artificial Intelligence in Translational Medicine
Brogi, S., & Calderone, V. (2021) · International Journal of Translational Medicine · doi:10.3390/ijtm1030016 · Cited by 8
National Institutes of Health (NIH) Workshop on Reaction InformaticsPreprint
Warr, W. A. (2021) · ChemRxiv · doi:10.33774/chemrxiv-2021-x5sj7 · Cited by 7
Intelligent Fusion
Jadwal, P. K., & Saini, H. K. (2025) · Wiley eBooks · doi:10.1002/9781394271382.ch3 · Cited by 7
Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting
Wang, J., Jiang, N., Liu, F., Wang, C., & Zhou, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108761 · Cited by 6
3D molecular generation models expand chemical space exploration in drug design
Xiang, Y.-T., Huang, G.-Y., Shi, X.-X., Hao, G., & Yang, G. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104282 · Cited by 7
Multi-Criteria Decision Analysis in Drug Discovery
Bachorz, R. A., Lawless, M. S., Miller, D. W., & Jones, J. O. (2025) · Applied Biosciences · doi:10.3390/applbiosci4010002 · Cited by 6
CMOMO: a deep multi-objective optimization framework for constrained molecular multi-property optimization
Xia, X., Zhang, Y., Zeng, X., Zhang, X., Zheng, C.-H., & Su, Y. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf335 · Cited by 7
Integrating statistical design and inference: A roadmap for robust and trustworthy medical AI
Wei, Q., Cui, M., Liu, Z., Liu, Z., Feng, G., Li, Y., Christiani, D. C., Li, L., Wang, J., Hao, Y., et al. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100145 · Cited by 6
Strategies for the drug development of cancer therapeutics
Liu, H., Ma, Y., Chen, W., Gu, X., Sun, J., & Li, P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1656012 · Cited by 7
Stereochemistry-aware string-based molecular generation
Tom, G., Yu, E., Yoshikawa, N., Jorner, K., & Aspuru‐Guzik, A. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf329 · Cited by 7
Self-citation
Leveraging Artificial Intelligence and Modulation of Oxidative Stressors to Enhance Healthspan and Radical Longevity
Haines, D. D., Rose, S. A., Cowan, F. M., Mahmoud, F. F., Rizvanov, A. A., & Tósaki, Á. (2025) · Biomolecules · doi:10.3390/biom15111501 · Cited by 7
Advancing cancer care through artificial intelligence: from innovative models to clinical decision-making and regulatory integration
Subhan, A., & Manoharan, G. (2025) · Clinical Cancer Bulletin · doi:10.1007/s44272-025-00052-0 · Cited by 9
Cell-Mediated and Peptide-Based Delivery Systems: Emerging Frontiers in Targeted Therapeutics
Erdei, E., Deme, R., Balogh, B., & Mándity, I. M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121597 · Cited by 8
Can artificial intelligence transform antiviral drug discovery?
Tirosyan, I., Gabrielyan, Y., Petrosyan, V., Vignuzzi, M., & Zakaryan, H. S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104648 · Cited by 6
VeGA-RX and VeGA-SCX: Controllable SMARTS-Guided Generative Transformers for Precision-Driven De Novo Drug Design
Delre, P., Bellofatto, G., & Lavecchia, A. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00535 · Cited by 6
İLAÇ KEŞFİ VE GELİŞTİRİLMESİNDE YAPAY ZEKÂ
Çelik, İ. N., ARSLAN, F. K., Tunç, R., & Yıldız, İ. (2021) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.878041 · Cited by 6
Virtual Screening of Nrf2 Dietary-Derived Agonists and Safety by a New Deep-Learning Model and Verified In Vitro and In Vivo
Liu, S., Qin, H.-H., Ji, X., Gan, J.-W., Sun, M., Tao, J., Tao, Z.-Q., Zhao, G., & Ma, B. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00867 · Cited by 6
A roadmap for exploring the untouched protein space for biology and medicine
Wang, J. (2023) · hLife · doi:10.1016/j.hlife.2023.06.001 · Cited by 6
Deep learning-based design and screening of benzimidazole-pyrazine derivatives as adenosine A 2B receptor antagonists
Qin, R., Zhang, H., Huang, W., Shao, Z., & Lei, J. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2295974 · Cited by 6
RM-GPT: Enhance the comprehensive generative ability of molecular GPT model via LocalRNN and RealFormer
Fan, W., He, Y., & Zhu, F. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.102827 · Cited by 7
Trends in research on AI-aided drug discovery from 2009 to 2023: A 15-year bibliometric analysis
Jiang, W., & Zhao, Z. (2024) · Intelligent Pharmacy · doi:10.1016/j.ipha.2024.09.001 · Cited by 6
Recent Development, Applications, and Patents of Artificial Intelligence in Drug Design and Development
Kumar, P., Mahor, A., & Tomar, R. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638364199250123062248 · Cited by 6
Syn-MolOpt: a synthesis planning-driven molecular optimization method using data-derived functional reaction templates
Yin, X., Wang, X., Wu, Z., Li, Q., Kang, Y., Deng, Y., Luo, P., Liu, H., Shi, G., Wang, Z., et al. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00975-9 · Cited by 6
Machine Learning Applications in Drug Discovery
Ugurlu, S. Y., McDonald, D., & He, S. (2025) · French-Ukrainian Journal of Chemistry · doi:10.17721/fujcv13i1p1-66 · Cited by 6

Authors: Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., Volkov, Y., Zholus, A., Shayakhmetov, R. R., Zhebrak, A., Minaeva, L. I., Zagribelnyy, B. A., Lee, L. H., Soll, R., Madge, D., Xing, L., Guo, T., & Aspuru-Guzik, A.
Affiliations: WuXi AppTec (China) (CN)
Corresponding author: Zhavoronkov, Alex
ORCID: Zhavoronkov, Alex
Ivanenkov, Yan A.
Aliper, Alex
Veselov, Mark S.
Aladinskiy, Vladimir A.
Terentiev, Victor A.
Polykovskiy, Daniil A.
Kuznetsov, Maksim D.
Asadulaev, Arip
Zholus, Artem
Shayakhmetov, Rim R.
Zhebrak, Alexander
Minaeva, Lidiya I.
Zagribelnyy, Bogdan A.
Lee, Lennart H.
Guo, Tao
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2019-09
Volume: 37
Issue: 9
Pages: 1038-1040
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/s41587-019-0224-x
OpenAlex: W2971690404
Cited by: 1,573
References: 57
Citations by year: 2026: 320 · 2025: 306 · 2024: 224 · 2023: 178 · 2022: 169 · 2021: 206 · 2020: 144 · 2019: 22
FWCI: 92.35
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
Funders: Nvidia
Nature
School of Medicine, University of New Mexico
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords: DDR1, deep generative models, drug discovery, fibrosis, pharmacokinetics
MeSH terms: Discoidin Domain Receptor 1, Deep Learning, Animals, Dogs, Drug Evaluation, Preclinical, Enzyme Inhibitors, Humans, Microsomes, Liver, Models, Molecular, Protein Conformation, Molecular Structure, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks